N ANTHONY COLES Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for N ANTHONY COLES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of N ANTHONY COLES. N ANTHONY COLES is Director in MCKESSON CORP ($MCK) and Director in REGENERON PHARMACEUTICALS INC ($REGN) and SVP, Comm. Ops. in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Executive Chair in YUMANITY THERAPEUTICS, INC. ($PTI) and Director in CRISPR Therapeutics AG ($CRSP) and President and CEO in Cerevel Therapeutics Holdings, Inc. ($ARYB).
Latest Insider Trading Transactions of N ANTHONY COLES
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CERE, CRSP, MCK, REGN, VRTX, YMTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | YMTX | YUMANITY THERAPEUT ... | COLES N ANTHONY | Executive Chair | Option Exercise | A | 19.64 | 78,650 | 1,544,686 | 78,650 | |
| Feb 05 2021 | ARYB | Cerevel Therapeuti ... | COLES N ANTHONY | President and CEO | Option Exercise | A | 12.70 | 732,714 | 9,305,468 | 732,714 | |
| Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | COLES N ANTHONY | Executive Chair | Option Exercise | A | 24.05 | 6,038 | 145,214 | 6,038 | |
| Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | COLES N ANTHONY | Executive Chair | Option Exercise | A | 8.16 | 12,082 | 98,589 | 12,082 | |
| Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | COLES N ANTHONY | Executive Chair | Option Exercise | A | 8.16 | 72,496 | 591,567 | 72,496 | |
| Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | COLES N ANTHONY | Executive Chair | Grant | A | 0.00 | 52,669 | 0 | 52,669 | 0 to 52.7 K |
| Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | COLES N ANTHONY | Executive Chair | Grant | A | 0.00 | 689,890 | 0 | 689,890 | 0 to 689.9 K |
| Nov 13 2020 | REGN | REGENERON PHARMACE ... | COLES N ANTHONY | Director | Option Exercise | M | 345.47 | 11 | 3,800 | 13,039 | |
| Nov 13 2020 | REGN | REGENERON PHARMACE ... | COLES N ANTHONY | Director | Buy | M | 345.47 | 11 | 3,800 | 654 | 643 to 654 (+1.71 %) |
| Oct 30 2020 | ARYB | Cerevel Therapeuti ... | COLES N ANTHONY | President and CEO | Option Exercise | A | 9.88 | 196,335 | 1,939,790 | 196,335 | |
| Aug 19 2020 | MCK | MCKESSON CORP | COLES N ANTHONY | Director | Sell | S | 156.77 | 2,453 | 384,559 | 0 | 2.5 K to 0 (-100.00 %) |
| Jul 31 2020 | MCK | MCKESSON CORP | COLES N ANTHONY | Director | Grant | A | 0.00 | 1,157 | 0 | 2,453 | 1.3 K to 2.5 K (+89.27 %) |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | COLES N ANTHONY | Director | Option Exercise | A | 374.12 | 4,361 | 1,631,537 | 4,361 | |
| Jan 06 2020 | REGN | REGENERON PHARMACE ... | COLES N ANTHONY | Director | Grant | A | 0.00 | 320 | 0 | 643 | 323 to 643 (+99.07 %) |
| Aug 01 2019 | MCK | MCKESSON CORP | COLES N ANTHONY | Director | Grant | A | 0.00 | 1,296 | 0 | 1,296 | 0 to 1.3 K |
| Sep 04 2018 | MCK | MCKESSON CORP | COLES N ANTHONY | Director | Sell | S | 128.69 | 1,350 | 173,732 | 0 | 1.4 K to 0 (-100.00 %) |
| Jul 26 2018 | MCK | MCKESSON CORP | COLES N ANTHONY | Director | Grant | A | 0.00 | 1,350 | 0 | 1,350 | 0 to 1.4 K |
| Jan 04 2018 | REGN | REGENERON PHARMACE ... | COLES N ANTHONY | Director | Option Exercise | A | 380.95 | 6,909 | 2,631,984 | 6,909 | |
| Jul 27 2017 | MCK | MCKESSON CORP | COLES N ANTHONY | Director | Option Exercise | A | 0.00 | 1,083 | 0 | 1,083 | |
| Jan 31 2017 | REGN | REGENERON PHARMACE ... | COLES N ANTHONY | Director | Option Exercise | A | 345.47 | 13,050 | 4,508,384 | 13,050 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | COLES N ANTHONY | Director | Grant | A | 14.00 | 35,000 | 490,000 | 70,000 | 35 K to 70 K (+100.00 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | COLES N ANTHONY | Director | Grant | A | 14.00 | 35,000 | 490,000 | 70,000 | 35 K to 70 K (+100.00 %) |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | COLES N ANTHONY | Director | Option Exercise | A | 14.00 | 15,000 | 210,000 | 15,000 | |
| Jul 28 2016 | MCK | MCKESSON CORP | COLES N ANTHONY | Director | Option Exercise | A | 0.00 | 915 | 0 | 915 | |
| Jul 31 2015 | MCK | MCKESSON CORP | COLES N ANTHONY | Director | Option Exercise | A | 0.00 | 794 | 0 | 794 | |
| Jul 22 2005 | VRTX | VERTEX PHARMACEUTI ... | COLES N ANTHONY | SVP, Comm. Ops. | Option Exercise | A | 17.16 | 18,000 | 308,880 | 272,328 | |
| Feb 07 2005 | VRTX | VERTEX PHARMACEUTI ... | COLES N ANTHONY | SVP, Comm. Ops. | Option Exercise | A | 10.41 | 24,750 | 257,648 | 254,328 | |
| Feb 07 2005 | VRTX | VERTEX PHARMACEUTI ... | COLES N ANTHONY | SVP, Comm. Ops. | Grant | A | 0.01 | 5,700 | 57 | 74,540 | 68.8 K to 74.5 K (+8.28 %) |
| Oct 12 2004 | VRTX | VERTEX PHARMACEUTI ... | COLES N ANTHONY | SVP, Comm. Ops. | Option Exercise | A | 11.27 | 18,000 | 202,860 | 229,578 | |
| May 10 2004 | VRTX | VERTEX PHARMACEUTI ... | COLES N ANTHONY | SVP, Comm. Ops. | Grant | A | 0.01 | 65,000 | 650 | 68,840 | 3.8 K to 68.8 K (+1,692.71 %) |
| Mar 19 2004 | VRTX | VERTEX PHARMACEUTI ... | COLES N ANTHONY | SVP, Comm. Ops. | Option Exercise | A | 9.69 | 14,400 | 139,536 | 211,578 | |
| Mar 19 2004 | VRTX | VERTEX PHARMACEUTI ... | COLES N ANTHONY | SVP, Comm. Ops. | Grant | A | 0.01 | 1,920 | 19 | 3,840 | 1.9 K to 3.8 K (+100.00 %) |
Page: 1